Millennium Management LLC's Schedule 13G Filing for Beta Bionics, Inc.

Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, filed a Schedule 13G with the SEC regarding their beneficial ownership of Beta Bionics, Inc. The filing indicates that these entities collectively own 5.3% of the company's common stock, par value $0.0001 per share. The shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander. The filing was made under Rule 13d-1(c) and includes a Joint Filing Agreement dated September 18, 2025. The filing certifies that the securities were not acquired for the purpose of influencing the control of the issuer.